Is the routine use of trimodality therapy for selected patients with non-small cell lung cancer supported by long-term clinical outcomes?
Department of Surgery,  VU University Medical Center, Amsterdam, The Netherlands.|Department of Cardiothoracic Surgery, VU University Medical Center, Amsterdam, The Netherlands.
C
C
Dickhoff
Department of Surgery, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam.
K J
KJ
Hartemink
Department of Surgery,  VU University Medical Center, Amsterdam, The Netherlands.
J
J
Kooij
Departments of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands.
P M
PM
van de Ven
Department of Cardiothoracic Surgery, VU University Medical Center, Amsterdam, The Netherlands.
M A
MA
Paul
Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands.|Department of Thoracic Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
E F
EF
Smit
Department of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands.
M
M
Dahele
D000328:Adult; D000368:Aged; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D059248:Chemoradiotherapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011013:Pneumonectomy; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome